Why Manuscripts Get Rejected: The Real Reasons by Stage and Discipline (2026)

1. Scope mismatch

In a study of 898 rejected manuscripts from a psychiatric journal, 17.4% of desk rejections were attributed to being out of scope. At journals with tighter editorial mandates (high-impact generalist journals, subspecialty journals with strict topical focus), the proportion is higher.

Scope mismatch is not always obvious. A paper can appear to be in scope based on subject matter but still fail the fit test because:

• The journal publishes mechanistic work and your study is descriptive epidemiology
• The journal's readership is basic scientists and your clinical application study lacks translational depth
• The journal covers the topic but recently published a competing paper that your manuscript does not address

At Elsevier journals, the carbon science journal Carbon offers a documented example: papers "containing carbon materials" that focus on properties unrelated to carbon science get desk-rejected even though carbon appears throughout. The journal wants carbon-science papers, not papers that use carbon. This editorial philosophy is specific, not obvious, and not detectable by reading the aims-and-scope paragraph alone.

The failure pattern that trips up experienced researchers: Submitting to the journal that "sounds right" rather than reading the last 12 months of published issues to verify editorial direction.

2. Novelty signaling failure

In the same psychiatric journal study, 51.8% of desk rejections cited lack of novelty or originality, making it the single most common cause of desk rejection by a large margin. This is also the most commonly misunderstood rejection reason.

Editors are not always saying the research itself lacks novelty. They are often saying the manuscript did not make the case for its novelty clearly enough.

An editor reading 40 submissions per week spends 2-5 minutes on initial triage. If the abstract, introduction, and conclusion do not make the contribution explicit and compelling in that window, the paper is desk-rejected on perceived novelty, even if the actual finding is genuinely new.

The failure pattern that trips up technically strong papers: A methods-first narrative structure that buries the contribution. The abstract describes the study design in paragraph one, the methods in paragraph two, and the finding in paragraph three. By then, the editor has already formed an impression.

A paper with a genuine finding should lead with that finding in the abstract's first sentence, position it against what was known, and make the gap explicit. "We show that X, overturning the assumption that Y" is a novelty claim. "In this study, we examined the role of X in Y using [method]" is a method description.

3. Formatting and readiness failures

These account for a smaller but entirely avoidable fraction of desk rejections. Common patterns:

• Figures not meeting resolution or formatting requirements
• Word count exceeding journal limits
• Missing sections the journal requires (ethics statement, data availability statement, CONSORT checklist for RCTs, PRISMA checklist for systematic reviews)
• Reference format that does not match the journal's style
• Simultaneous submission to multiple journals (violates most journal policies)

These are not interesting research problems. They are administrative failures that add friction for the editor and signal that the authors have not read the guide for authors carefully.

Once a manuscript clears desk review, the probability of eventual acceptance rises substantially. At journals where 70% of papers are desk-rejected, papers reaching reviewers have roughly 30-40% acceptance odds. But peer review rejection is still common, and the patterns are diagnosable.

Methodology gaps and causal overclaim

The most frequently cited peer review rejection reason in the Indian Journal of Psychological Medicine study was poor methodology elaboration (50.7% of post-peer-review rejections). In biomedical engineering journals, design flaws and unclear methodology are the leading post-review rejection causes.

The specific failure pattern that appears consistently across clinical and biomedical fields: an observational study using causal language when the design only supports correlation. A cross-sectional study concluding that "X causes Y" when the study can at most establish that X and Y are associated. A retrospective cohort study describing its results as "demonstrating" an effect when confounding is inadequately addressed.

This is not a minor wording problem. Peer reviewers in clinical medicine and epidemiology are trained to flag exactly this disconnect. A strong manuscript explicitly acknowledges design limitations, uses language calibrated to what the study can actually support ("our findings are consistent with," "suggest that," "we observed an association between"), and addresses confounding directly rather than in a brief limitations paragraph.

The specific pattern: An RCT-language conclusion ("this intervention improves outcomes") attached to an observational design. Any reviewer who has served on a clinical journal's editorial board flags this immediately.

Weak study rationale and contribution framing

In the same study, 45.2% of peer review rejections involved weak writing quality, and a large subset of those were problems with the study rationale, not just prose quality. The introduction sets up the gap the paper fills. If the gap is not real, or not described compellingly, or not connected to the actual findings, reviewers reject on "insufficient justification for the study."

A complete introduction establishes: what is known, what is not known, why the unknown part matters, and why this study addresses it. Studies that describe a background topic thoroughly without naming a specific gap get rejected at this step.

Statistical problems

Common statistical errors that cause peer review rejection include: inappropriate tests for the data structure (parametric tests applied to non-normally distributed data without justification), underpowered studies without sample-size justification, multiple comparisons without correction, and p-values misinterpreted as effect sizes.

A documented finding from published analysis of high-impact medical journal rejections: manuscripts with statistical co-authors are not measurably less likely to have statistical errors than those without. Having a statistician on the author list does not protect against statistical rejection if the methods and reporting are weak.

What the numbers mean for your strategy:

If most rejections happen at the desk stage, and most desk rejections are about scope and novelty signaling, then the highest-leverage pre-submission activity is verifying journal fit and sharpening the contribution framing, not revising the methods section again.

If you are getting desk rejections consistently, the problem is targeting or signaling. If you are getting peer review rejections consistently, the problem is likely methodology, statistical rigor, or claim strength.

At Nature, desk rejection rates reach 60-75%. Of papers that reach reviewers, roughly 38% eventually accept. At NEJM, desk rejection is 80-90%, but post-review acceptance is closer to 50% for papers that get that far. The editorial triage is doing a lot of work at flagship journals. Getting past the editor is the first and often hardest gate.

Generic rejection advice treats all manuscripts the same. In our pre-submission review work across 200+ journals spanning biomedical, chemistry, physics, and engineering disciplines, each field has failure patterns that are genuinely discipline-specific, not just generic "methodology problems."

A specific pattern from clinical medicine work: The CONSORT checklist where half the items say "see Methods" without page numbers or paragraph references. Journals with explicit CONSORT requirements expect the checklist to be completed as a document, not treated as a compliance box. A reviewer who is a clinical trialist will flag this in the first paragraph of their review.

A specific pattern from basic biomedical science: A figure panel with 12 representative images from what was presumably a larger dataset, with no statement of how many independent experiments the figure represents, no statistical test on the representative result, and an n in the methods that does not match the figure legend. Reviewers at journals like Cell, Nature Cell Biology, or Journal of Biological Chemistry are specifically trained to look for this disconnect.

In our pre-submission review work with manuscripts targeting journals across these disciplines, the failure patterns that generate the most consistent preventable rejections are the same ones described above. Not because they are hard to find, but because authors are too close to their own work to see them.

The novelty framing problem is invisible to the authors because they know the contribution is real. The causal language problem is invisible because the authors believe their data supports the conclusion. The scope mismatch is invisible because the journal name sounds right.

A structured pre-submission review, whether automated or expert-led, applies the same lens an editor uses in the first five minutes. It finds the scope fit problem before you wait three days for a desk rejection. It finds the methods-section gap before you wait six weeks for a reviewer to find it. It finds the statistical concern before a biostatistician reviewer writes a two-page report about it.

Run a free readiness scan at Manusights. It takes about 60 seconds and checks your manuscript against the editorial standards of your target journal.